516 related articles for article (PubMed ID: 15237111)
21. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.
Levings MK; Sangregorio R; Sartirana C; Moschin AL; Battaglia M; Orban PC; Roncarolo MG
J Exp Med; 2002 Nov; 196(10):1335-46. PubMed ID: 12438424
[TBL] [Abstract][Full Text] [Related]
22. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.
Itoh M; Takahashi T; Sakaguchi N; Kuniyasu Y; Shimizu J; Otsuka F; Sakaguchi S
J Immunol; 1999 May; 162(9):5317-26. PubMed ID: 10228007
[TBL] [Abstract][Full Text] [Related]
23. Co-stimulation of T cell proliferation by transforming growth factor-beta 1.
Lee HM; Rich S
J Immunol; 1991 Aug; 147(4):1127-33. PubMed ID: 1831218
[TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
25. The interleukin-10 inducing effect of transforming growth factor-beta on human naive CD4+ T cells from cord blood is restricted to the TH1 subset.
Kapitein B; Tiemessen MM; Liu WM; van Ieperen-van Dijk AG; Hoekstra MO; van Hoffen E; Knol EF
Clin Exp Immunol; 2007 Feb; 147(2):352-8. PubMed ID: 17223978
[TBL] [Abstract][Full Text] [Related]
26. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-beta inhibits human antigen-specific CD4+ T cell proliferation without modulating the cytokine response.
Tiemessen MM; Kunzmann S; Schmidt-Weber CB; Garssen J; Bruijnzeel-Koomen CA; Knol EF; van Hoffen E
Int Immunol; 2003 Dec; 15(12):1495-504. PubMed ID: 14645158
[TBL] [Abstract][Full Text] [Related]
28. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
Mukherjee S; Maiti PK; Nandi D
J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
[TBL] [Abstract][Full Text] [Related]
29. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.
Fehérvári Z; Sakaguchi S
Int Immunol; 2004 Dec; 16(12):1769-80. PubMed ID: 15520045
[TBL] [Abstract][Full Text] [Related]
30. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity.
Tsaknaridis L; Spencer L; Culbertson N; Hicks K; LaTocha D; Chou YK; Whitham RH; Bakke A; Jones RE; Offner H; Bourdette DN; Vandenbark AA
J Neurosci Res; 2003 Oct; 74(2):296-308. PubMed ID: 14515359
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
Kosiewicz MM; Alard P; Liang S; Clark SL
Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
[TBL] [Abstract][Full Text] [Related]
32. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.
Zheng SG; Wang JH; Gray JD; Soucier H; Horwitz DA
J Immunol; 2004 May; 172(9):5213-21. PubMed ID: 15100259
[TBL] [Abstract][Full Text] [Related]
33. Requirement of CD28 signaling in homeostasis/survival of TGF-beta converted CD4+CD25+ Tregs from thymic CD4+CD25- single positive T cells.
Liu Y; Amarnath S; Chen W
Transplantation; 2006 Oct; 82(7):953-64. PubMed ID: 17038912
[TBL] [Abstract][Full Text] [Related]
34. Regulatory T cells.
Thompson C; Powrie F
Curr Opin Pharmacol; 2004 Aug; 4(4):408-14. PubMed ID: 15251137
[TBL] [Abstract][Full Text] [Related]
35. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood.
Yamagiwa S; Gray JD; Hashimoto S; Horwitz DA
J Immunol; 2001 Jun; 166(12):7282-9. PubMed ID: 11390478
[TBL] [Abstract][Full Text] [Related]
36. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.
Cabrera R; Tu Z; Xu Y; Firpi RJ; Rosen HR; Liu C; Nelson DR
Hepatology; 2004 Nov; 40(5):1062-71. PubMed ID: 15486925
[TBL] [Abstract][Full Text] [Related]
37. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.
Yagi H; Nomura T; Nakamura K; Yamazaki S; Kitawaki T; Hori S; Maeda M; Onodera M; Uchiyama T; Fujii S; Sakaguchi S
Int Immunol; 2004 Nov; 16(11):1643-56. PubMed ID: 15466453
[TBL] [Abstract][Full Text] [Related]
38. A novel costimulation pathway via the 4C8 antigen for the induction of CD4+ regulatory T cells.
Masuyama J; Kaga S; Kano S; Minota S
J Immunol; 2002 Oct; 169(7):3710-6. PubMed ID: 12244164
[TBL] [Abstract][Full Text] [Related]
39. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
[TBL] [Abstract][Full Text] [Related]
40. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
Fehr T; Takeuchi Y; Kurtz J; Wekerle T; Sykes M
Eur J Immunol; 2005 Sep; 35(9):2679-90. PubMed ID: 16082727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
